{
  "retracted": false,
  "timestamp": 973036800000,
  "updates": [
    {
      "timestamp": 1591363578106,
      "identifier": {
        "doi": "10.1038/80516"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/82242"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Encephalitogenic potential of the myelin basic protein peptide (amino acids 83â€“99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand"
}
